Table 10.
Multicenter comparison of anatomic location of uveitis
| UVA | Centers
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United states
|
International
|
|||||||||
| MEEI3 | Duke5 | IA*10 | UCLA*9 | USC11 | KY1 | REH8 | SBU7 | UM6 | ||
| Time period | 1984–2014 | 1982–1992 | 1989–1994 | 1956–1960 | 1991–1994 | 2006–2007 | 1990–1995 | 1991–2013 | – | 2006–2010 |
| Patients (N) | 491 | 1,237 | 385 | 172 | 213 | 217,061 | 853 | 3,301 | 2,693 (ME) 4,379 (EU) |
43 (FN) 45 (control) |
| Anterior uveitis (%) | 67.6 | 51.6 | 25 | 60.0 (I) 63.0 (L) |
90.6 (CBP) 60.6 (URP) |
72 | 22.3 | 46 | 49.6 (ME) 51.3 (EU) |
26.0 (FN) 73.0 (control) |
| Posterior uveitis (%) | 12.6 | 17.4 | 24 | 29 (I) 19 (L) |
4.7 (CBP) 14.6 (URP) |
29 | 48.4 | 21.8 | 15.5 (ME) 23.7 (EU) |
7.0 (FN) 2.0 (control) |
| Intermediate uveitis (%) | 5.3 | 13 | 12 | 6 | 1.4 (CBP) 12.2 (URP) |
6 | 10.9 | 11.1 | 10.3 (ME) 9.1 (EU) |
0.0 (FN) 9.0 (control) |
| Panuveitis (%) | 14.5 | 16 | 38 | 10.0 (I) 18.0 (L) |
1.4 (CBP) 9.4 (URP) |
21 | 18.4 | 21.1 | 24.9 (ME) 15.9 (EU) |
67.0 (FN) 16.0 (control) |
Notes:
*
IA and UCLA frequencies extrapolated from data, as different localization systems used.
Abbreviations: UVA, University of Virginia; MEEI, Massachusetts Eye and Ear Infirmary; Duke, Duke University; IA, University of Iowa; UCLA, University of California at Los Angeles; USC, University of Southern California; KY, University of Louisville, Kentucky; REH, The Royal Eye Hospital, Manchester, UK; SBU, Shahid Beheshti University of Medical Sciences, Tehran, Iran; UM, University of Manitoba, Winnipeg, Canada; ME, Middle East; EU, Europe; FN, First Nation; L, London; I, Iowa; CBP, Community Based Practice; URP, University Referral Practice.